172 related articles for article (PubMed ID: 19234496)
1. JUPITER strikes earth.
Fuster V; Bansilal S
Nat Clin Pract Cardiovasc Med; 2009 Mar; 6(3):159. PubMed ID: 19234496
[No Abstract] [Full Text] [Related]
2. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Feeman WE
Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577687
[No Abstract] [Full Text] [Related]
3. The JUPITER Trial: responding to the critics.
Ridker PM; Glynn RJ
Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
[No Abstract] [Full Text] [Related]
4. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
[TBL] [Abstract][Full Text] [Related]
5. Is rosuvastatin really a more efficient therapeutic option than atorvastatin?
Soto J; Fernandez de Bobadilla J
Value Health; 2006; 9(4):276-7; author reply 277-9. PubMed ID: 16903999
[No Abstract] [Full Text] [Related]
6. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
de Tena JG
Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577686
[No Abstract] [Full Text] [Related]
7. Jupiter to Earth: CRP promotes atherothrombosis.
Jialal I; Devaraj S
Metab Syndr Relat Disord; 2009 Feb; 7(1):1-3. PubMed ID: 19183073
[No Abstract] [Full Text] [Related]
8. Expanding the orbit of primary prevention--moving beyond JUPITER.
Hlatky MA
N Engl J Med; 2008 Nov; 359(21):2280-2. PubMed ID: 18997195
[No Abstract] [Full Text] [Related]
9. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Sniderman AD
Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577690
[No Abstract] [Full Text] [Related]
10. Bringing JUPITER down to earth.
Després JP
Lancet; 2009 Apr; 373(9670):1147-8. PubMed ID: 19329179
[No Abstract] [Full Text] [Related]
11. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Rosenstein R; Parra D
Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577689
[No Abstract] [Full Text] [Related]
12. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Danchin N
Lancet; 2009 Jul; 374(9683):24-5; author reply 26-7. PubMed ID: 19577685
[No Abstract] [Full Text] [Related]
13. The Jupiter trial: key findings, controversies, and implications.
Nissen SE
Curr Cardiol Rep; 2009 Mar; 11(2):81-2. PubMed ID: 19236822
[No Abstract] [Full Text] [Related]
14. Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.
Nicholls SJ; Uno K; Kataoka Y
Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1383-90. PubMed ID: 22059787
[TBL] [Abstract][Full Text] [Related]
15. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.
Ridker PM; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Khurmi NS; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Am J Cardiol; 2007 Dec; 100(11):1659-64. PubMed ID: 18036365
[TBL] [Abstract][Full Text] [Related]
16. [Comment from the cardiologic viewpoint].
Lüscher TF
Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
[No Abstract] [Full Text] [Related]
17. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Segura J; Ruilope LM
Lancet; 2009 Jul; 374(9683):26; author reply 26-7. PubMed ID: 19577691
[No Abstract] [Full Text] [Related]
18. Is hsCRP Back on Board? Implications from the JUPITER Trial.
Koenig W
Clin Chem; 2009 Feb; 55(2):216-8. PubMed ID: 19074517
[No Abstract] [Full Text] [Related]
19. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.
Ridker PM; Genest J; Boekholdt SM; Libby P; Gotto AM; Nordestgaard BG; Mora S; MacFadyen JG; Glynn RJ; Kastelein JJ;
Lancet; 2010 Jul; 376(9738):333-9. PubMed ID: 20655105
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological and clinical profile of rosuvastatin calcium (Crestor)].
Ohfuji K; Yano S; Yamaguchi M; Smith G; Hirata M; Shimada H; Izuishi K; Shinagawa J; Matsunaga K
Nihon Yakurigaku Zasshi; 2005 Sep; 126(3):213-9. PubMed ID: 16272766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
